AAAAAA

   
Results: 1-12 |
Results: 12
CONTINUOUS-INFUSION OF 5-FLUOROURACIL (CIFU) GIVEN WITH VINORELBINE (VI) AND CISPLATIN (P) (VIFUP) IN HEAVILY PRETREATED METASTATIC BREAST-CANCER
Authors: NOLE F MUNZONE E ZAMPINO MG MINCHELLA I COLLEONI M NOBERASCO C DEPAS T FAZIO N DEBRAUD F PERUZZOTTI G GOLDHIRSCH A
Citation: F. Nole et al., CONTINUOUS-INFUSION OF 5-FLUOROURACIL (CIFU) GIVEN WITH VINORELBINE (VI) AND CISPLATIN (P) (VIFUP) IN HEAVILY PRETREATED METASTATIC BREAST-CANCER, European journal of cancer, 34, 1998, pp. 33-33
PHARMACOKINETICS OF ANTICANCER AGENTS IN PATIENTS WITH IMPAIRED LIVER-FUNCTION
Authors: DONELLI MG ZUCCHETTI M MUNZONE E DINCALCI M CROSIGNANI A
Citation: Mg. Donelli et al., PHARMACOKINETICS OF ANTICANCER AGENTS IN PATIENTS WITH IMPAIRED LIVER-FUNCTION, European journal of cancer, 34(1), 1998, pp. 33-46
HIGH-DOSE IFOSFAMIDE PLUS ADRIAMYCIN IN THE TREATMENT OF ADULT ADVANCED SOFT-TISSUE SARCOMAS - IS IT FEASIBLE
Authors: DEPAS T DEBRAUD F ORLANDO L NOLE F MUNZONE E ZAMPINO MG FAZIO N AAPRO MS GOLDHIRSCH A
Citation: T. Depas et al., HIGH-DOSE IFOSFAMIDE PLUS ADRIAMYCIN IN THE TREATMENT OF ADULT ADVANCED SOFT-TISSUE SARCOMAS - IS IT FEASIBLE, Annals of oncology, 9(8), 1998, pp. 917-919
CA-19.9 SERUM MARKER AS A PREDICTOR OF RESPONSE TO CHEMOTHERAPY (CT) IN LOCALLY ADVANCED (LA) AND METASTATIC (M) PANCREATIC-CANCER (PC) PATIENTS
Authors: MUNZONE E DEBRAUD F BAGLIETTO L ORLANDO L GOLDHIRSCH A
Citation: E. Munzone et al., CA-19.9 SERUM MARKER AS A PREDICTOR OF RESPONSE TO CHEMOTHERAPY (CT) IN LOCALLY ADVANCED (LA) AND METASTATIC (M) PANCREATIC-CANCER (PC) PATIENTS, Annals of oncology, 9, 1998, pp. 247-247
SCINTIGRAPHIC IMAGING AND TURNOVER STUDIES WITH I-131-LABELED SERUM AMYLOID-P COMPONENT IN SYSTEMIC AMYLOIDOSIS
Authors: HAWKINS PN APRILE C CAPRIA G VIGANO L MUNZONE E GIANNI L PEPYS MB MERLINI G
Citation: Pn. Hawkins et al., SCINTIGRAPHIC IMAGING AND TURNOVER STUDIES WITH I-131-LABELED SERUM AMYLOID-P COMPONENT IN SYSTEMIC AMYLOIDOSIS, European journal of nuclear medicine, 25(7), 1998, pp. 701-708
SYNERGISTIC ACTIVITY OF OXALIPLATIN AND 5-FLUOROURACIL IN PATIENTS WITH METASTATIC COLORECTAL-CANCER WITH PROGRESSIVE DISEASE WHILE ON OR AFTER 5-FLUOROURACIL
Authors: DEBRAUD F MUNZONE E NOLE F DEPAS T BIFFI R BRIENZA S AAPRO MS
Citation: F. Debraud et al., SYNERGISTIC ACTIVITY OF OXALIPLATIN AND 5-FLUOROURACIL IN PATIENTS WITH METASTATIC COLORECTAL-CANCER WITH PROGRESSIVE DISEASE WHILE ON OR AFTER 5-FLUOROURACIL, American journal of clinical oncology, 21(3), 1998, pp. 279-283
IDARUBICIN AND MELPHALAN AS MYELOABLATIVE REGIMEN AFTER SEQUENTIAL HIGH-DOSE CHEMOTHERAPY FOR LYMPHOMAS - PRELIMINARY-RESULTS OF A PHASE I-II STUDY WITH PHARMACOKINETIC GUIDED PERIPHERAL-BLOOD PROGENITOR-CELL REINFUSION
Authors: PECCATORI F COCOROCCHIO E MUNZONE E CORSINI C ZUCCHETTI M FERRUCCI PF CINIERI S DINCALCI M MARTINELLI G
Citation: F. Peccatori et al., IDARUBICIN AND MELPHALAN AS MYELOABLATIVE REGIMEN AFTER SEQUENTIAL HIGH-DOSE CHEMOTHERAPY FOR LYMPHOMAS - PRELIMINARY-RESULTS OF A PHASE I-II STUDY WITH PHARMACOKINETIC GUIDED PERIPHERAL-BLOOD PROGENITOR-CELL REINFUSION, Blood, 90(10), 1997, pp. 4381-4381
PACLITAXEL IN METASTATIC BREAST-CANCER - A TRIAL OF 2 DOSES BY A 3-HOUR INFUSION IN PATIENTS WITH DISEASE RECURRENCE AFTER PRIOR THERAPY WITH ANTHRACYCLINES
Authors: GIANNI L MUNZONE E CAPRI G VILLANI F SPREAFICO C TARENZI E FULFARO F CARACENI A MARTINI C LAFFRANCHI A VALAGUSSA P BONADONNA G
Citation: L. Gianni et al., PACLITAXEL IN METASTATIC BREAST-CANCER - A TRIAL OF 2 DOSES BY A 3-HOUR INFUSION IN PATIENTS WITH DISEASE RECURRENCE AFTER PRIOR THERAPY WITH ANTHRACYCLINES, Journal of the National Cancer Institute, 87(15), 1995, pp. 1169-1175
PACLITAXEL BY 3-H ON DAY 1 AND 8 EVERY 3-WEEKS IN WOMEN WITH ANTHRACYCLINE-RESISTANT METASTATIC BREAST-CANCER
Authors: GIANNI L FULFARO F TARENZI E MUNZONE E CAPRI G LAFFRANCHI A SPREAFICO C CRABEELS D BONADONNA G
Citation: L. Gianni et al., PACLITAXEL BY 3-H ON DAY 1 AND 8 EVERY 3-WEEKS IN WOMEN WITH ANTHRACYCLINE-RESISTANT METASTATIC BREAST-CANCER, European journal of cancer, 31A, 1995, pp. 359-359
PACLITAXEL BY 3-HOUR INFUSION IN COMBINATION WITH BOLUS DOXORUBICIN IN WOMEN WITH UNTREATED METASTATIC BREAST-CANCER - HIGH ANTITUMOR EFFICACY AND CARDIAC EFFECTS IN A DOSE-FINDING AND SEQUENCE-FINDING STUDY
Authors: GIANNI L MUNZONE E CAPRI G FULFARO F TARENZI E VILLANI F SPREAFICO C LAFFRANCHI A CARACENI A MARTINI C STEFANELLI M VALAGUSSA P BONADONNA G
Citation: L. Gianni et al., PACLITAXEL BY 3-HOUR INFUSION IN COMBINATION WITH BOLUS DOXORUBICIN IN WOMEN WITH UNTREATED METASTATIC BREAST-CANCER - HIGH ANTITUMOR EFFICACY AND CARDIAC EFFECTS IN A DOSE-FINDING AND SEQUENCE-FINDING STUDY, Journal of clinical oncology, 13(11), 1995, pp. 2688-2699
VISUAL-EVOKED POTENTIALS FINDINGS IN COURSE OF PACLITAXEL DOXORUBICINCOMBINATION CHEMOTHERAPY - REPORT OF A CASE
Authors: SCAIOLI V CARACENI A MARTINI C PALAZZINI E TARENZI E FULFARO F MUNZONE E
Citation: V. Scaioli et al., VISUAL-EVOKED POTENTIALS FINDINGS IN COURSE OF PACLITAXEL DOXORUBICINCOMBINATION CHEMOTHERAPY - REPORT OF A CASE, Journal of neuro-oncology, 25(3), 1995, pp. 221-225
PACLITAXEL (TAXOL) EFFICACY IN PATIENTS WITH ADVANCED BREAST-CANCER RESISTANT TO ANTHRACYCLINES
Authors: GIANNI L CAPRI G MUNZONE E STRANEO M
Citation: L. Gianni et al., PACLITAXEL (TAXOL) EFFICACY IN PATIENTS WITH ADVANCED BREAST-CANCER RESISTANT TO ANTHRACYCLINES, Seminars in oncology, 21(5), 1994, pp. 29-33
Risultati: 1-12 |